Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings—a meta-analysis

被引：0
|
作者：
Karin Jordan
David G. Warr
Axel Hinke
Linda Sun
Paul J. Hesketh
机构：
[1] Martin-Luther- University Halle-Wittenberg,Department of Internal Medicine IV, Hematology/Oncology
[2] Princess Margaret Hospital,Department of Hematology Oncology
[3] WiSP Wissenschaftlicher Service Pharma GmbH,undefined
[4] Merck & Co.,undefined
[5] Inc.,undefined
[6] Lahey Hospital & Medical Center,undefined
来源：
Supportive Care in Cancer | 2016年 / 24卷
关键词：
Chemotherapy-induced nausea and vomiting; Emetogenicity; Neurokinin-1 receptor; Antiemetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1941 / 1954
页数：13
相关论文
共 50 条
  • [21] Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting
    Navari, Rudolph M.
    Schwartzberg, Lee S.
    ONCOTARGETS AND THERAPY, 2018, 11 : 6459 - 6478
  • [22] Neurokinin 1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitant
    Rapoport, Bernardo L.
    Jordan, Karin
    Weinstein, Cindy
    FUTURE ONCOLOGY, 2018, 14 (01) : 77 - 92
  • [23] Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists
    Snežana M. Bošnjak
    Richard J. Gralla
    Lee Schwartzberg
    Supportive Care in Cancer, 2017, 25 : 1661 - 1671
  • [24] Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists
    Bosnjak, Snezana M.
    Gralla, Richard J.
    Schwartzberg, Lee
    SUPPORTIVE CARE IN CANCER, 2017, 25 (05) : 1661 - 1671
  • [25] Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting
    Hargreaves, Richard
    Ferreira, Juan Camilo Arjona
    Hughes, David
    Brands, Jos
    Hale, Jeff
    Mattson, Britta
    Mills, Sandy
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: WINNERS AND FINALIST CANDIDATES OF THE PRIX GALIEN USA, INTERNATIONAL, AND PRO BONO HUMANITARIAN AWARDS 2010, 2011, 1222 : 40 - 48
  • [26] Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting
    Diemunsch, P.
    Joshi, G. P.
    Brichant, J. -F.
    BRITISH JOURNAL OF ANAESTHESIA, 2009, 103 (01) : 7 - 13
  • [27] Neurokinin-1 receptor antagonists for the prevention of postoperative nausea and vomiting
    Meyer, Tricia A.
    Habib, Ashraf S.
    Wagner, Deborah
    Gan, Tong J.
    PHARMACOTHERAPY, 2023, 43 (09): : 922 - 934
  • [28] Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy
    Rapoport, Bernardo
    Smit, Teresa
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (06) : 697 - 710
  • [29] Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting
    Navari, Rudolph M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (12) : 1977 - 1985
  • [30] Efficacy of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting: a meta-analysis
    Yang, Ting
    Liu, Qianxin
    Lu, Min
    Ma, Lingyue
    Zhou, Ying
    Cui, Yimin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (07) : 1369 - 1379
12345